查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886572

酵素傷口清創市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、產品、最終用途、地區和競爭格局分類，2020-2030年預測

Enzymatic Wound Debridement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End-Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球酵素傷口清創市場規模為11.9億美元，預計2030年將以6.77%的複合年成長率成長至17.6億美元。酵素傷口清創是指局部應用外源性酶，選擇性地清除傷口床中的壞死或無活性組織，從而促進傷口自然癒合。這個市場的成長主要受慢性傷口（如糖尿病足潰瘍和壓瘡）在全球範圍內日益普遍以及老年人口不斷成長（老年人更容易出現傷口癒合障礙）的雙重驅動。

市場概覽
預測期 2026-2030
市場規模：2024年 11.9億美元
市場規模：2030年 17.6億美元
複合年成長率：2025-2030年 6.77%
成長最快的細分市場 慢性傷口
最大的市場 北美洲

主要市場促進因素

慢性傷口的日益普遍顯著推動了全球酵素傷口清創市場的發展。糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等疾病需要有效的清創術來去除壞死組織並促進癒合。

主要市場挑戰

全球酵素傷口清創市場擴張的一大障礙是這些產品相對於其他清創方法而言價格較高。這種高昂的價格直接影響了其應用率，尤其是在對成本高度敏感、預算限制是首要考慮因素的醫療環境中。

主要市場趨勢

全球酵素傷口清創市場的一個顯著趨勢是，治療模式正從傳統的住院治療轉向門診和居家照護。這項轉變的驅動力在於提高病患舒適度和降低治療成本。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球酵素傷口清創市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（慢性傷口、急性傷口）
    • 依產品（膠原蛋白酶產品、木瓜蛋白酶產品、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美酵素傷口清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲酵素傷口清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區酵素傷口清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲酵素傷口清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲酵素傷口清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球酵素傷口清創市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Convatec Limited
  • Smith & Nephew Plc
  • Molnlycke Health Care AB
  • Integra LifeSciences Corporation
  • SolasCure Limited
  • B. Braun SE
  • Healthpoint, Ltd
  • MediWound Ltd.
  • 3M Company
  • HARTMANN UK&I

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 24093

The Global Enzymatic Wound Debridement Market, valued at USD 1.19 Billion in 2024, is projected to experience a CAGR of 6.77% to reach USD 1.76 Billion by 2030. Enzymatic wound debridement involves the topical application of exogenous enzymes to selectively remove necrotic or non-viable tissue from a wound bed, thereby facilitating the natural healing process. The market's expansion is primarily driven by the increasing global prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, alongside a growing geriatric population more susceptible to impaired wound healing.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.19 Billion
Market Size 2030USD 1.76 Billion
CAGR 2025-20306.77%
Fastest Growing SegmentChronic Wounds
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of chronic wounds significantly drives the global enzymatic wound debridement market. Conditions such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers require effective debridement to remove non-viable tissue and promote healing. The growing incidence of chronic diseases and an aging global population contribute directly to this patient demographic, creating a sustained demand for advanced wound care solutions.

Key Market Challenges

A significant impediment to the expansion of the global enzymatic wound debridement market is the comparatively high cost of these products relative to alternative debridement methods. This elevated pricing directly impacts adoption rates, particularly within cost-sensitive healthcare environments where budget constraints are a primary concern. Healthcare providers and institutions often prioritize cost-effectiveness, leading them to opt for less expensive debridement techniques despite the potential clinical benefits of enzymatic options.

Key Market Trends

The increasing shift from traditional inpatient hospital settings to outpatient clinics and home-based care models represents a significant trend in the global enzymatic wound debridement market. This transition is driven by desires for improved patient comfort and cost reduction.

Key Market Players

  • Convatec Limited
  • Smith & Nephew Plc
  • Molnlycke Health Care AB
  • Integra LifeSciences Corporation
  • SolasCure Limited
  • B. Braun SE
  • Healthpoint, Ltd
  • MediWound Ltd.
  • 3M Company
  • HARTMANN UK&I

Report Scope:

In this report, the Global Enzymatic Wound Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enzymatic Wound Debridement Market, By Type:

  • Chronic Wounds
  • Acute Wounds

Enzymatic Wound Debridement Market, By Product:

  • Collagenase Product
  • Papain Product
  • Others

Enzymatic Wound Debridement Market, By End Use:

  • Hospitals
  • Homecare
  • Others

Enzymatic Wound Debridement Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Enzymatic Wound Debridement Market.

Available Customizations:

Global Enzymatic Wound Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enzymatic Wound Debridement Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Chronic Wounds, Acute Wounds)
    • 5.2.2. By Product (Collagenase Product, Papain Product, Others)
    • 5.2.3. By End Use (Hospitals, Homecare, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Enzymatic Wound Debridement Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Enzymatic Wound Debridement Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Enzymatic Wound Debridement Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Enzymatic Wound Debridement Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End Use

7. Europe Enzymatic Wound Debridement Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Enzymatic Wound Debridement Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Enzymatic Wound Debridement Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Enzymatic Wound Debridement Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Enzymatic Wound Debridement Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Enzymatic Wound Debridement Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End Use

8. Asia Pacific Enzymatic Wound Debridement Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Enzymatic Wound Debridement Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Enzymatic Wound Debridement Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Enzymatic Wound Debridement Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Enzymatic Wound Debridement Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Enzymatic Wound Debridement Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Enzymatic Wound Debridement Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Enzymatic Wound Debridement Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Enzymatic Wound Debridement Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Enzymatic Wound Debridement Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End Use

10. South America Enzymatic Wound Debridement Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Enzymatic Wound Debridement Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Enzymatic Wound Debridement Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Enzymatic Wound Debridement Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Enzymatic Wound Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Convatec Limited
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Smith & Nephew Plc
  • 15.3. Molnlycke Health Care AB
  • 15.4. Integra LifeSciences Corporation
  • 15.5. SolasCure Limited
  • 15.6. B. Braun SE
  • 15.7. Healthpoint, Ltd
  • 15.8. MediWound Ltd.
  • 15.9. 3M Company
  • 15.10. HARTMANN UK&I

16. Strategic Recommendations

17. About Us & Disclaimer